Group items matching

in title, tags, annotations or url

The Green Party has previewed its upcoming manifesto with a bold proposal for the National Health Service (NHS) and social care system, promising an unprecedented level of investment to restore and enhance these critical services. By 2030, the Greens aim to inject over £50 billion annually into health and social care, accompanied by an additional £20 billion capital investment to modernise healthcare infrastructure. Green Party Co-Leader Adrian Ramsay emphasised the urgency of these reforms, stating, "Our NHS is at breaking point following 14 years of underfunding." "Patients are stuck in hospital corridors, people can't see their GP or NHS dentist when they need to, and staff are severely overstretched." The manifesto highlights a comprehensive approach to revitalising the NHS, including:

Knights Pharmacy has significantly expanded its footprint in South Wales through its recent acquisition of pharmacies in Abercarn and Cwmcarn from the Evans Group. This move marks another strategic expansion for the Redditch-based pharmacy group, bolstered by funding from HSBC UK. The Abercarn site, which handles approximately 12,000 medication items annually, and the Cwmcarn site, dispensing around 5,000 items, will now operate under the Knights Pharmacy banner. This acquisition adds to Knights Pharmacy's growing portfolio, which now spans 49 community sites across England and Wales, a substantial increase from 18 sites just three years ago.

The #AskAboutAsthma annual campaign, led by NHS England - London's Babies, Children and Young People programme, is returning for its eighth year with a focus on promoting simple changes that can make a big difference to people living with asthma. Scheduled to take place from 9-15 September, this year' campaign aims to address broader factors such as vaping, air quality, housing conditions, and mould to ensure every child and young person in London with asthma receives the support and tools necessary to manage their condition effectively. Pharmacists are encouraged to support the 2024 #AskAboutAsthma campaign, themed "helping children and young people with asthma to live their best lives." They can contribute to the campaign in various ways, including: Offering inhaler technique checks to all children and young people with asthma. Identifying children and young people who are not regularly collecting their preventer medication and communicating this to their GP practice. Identifying children and young people who are collecting large amounts of reliever medication and communicating this to their GP practice.

The Proprietary Association of Great Britain (PAGB) has called on the new Labour government to prioritise six key actions within its first 100 days to harness the benefits of self-care for the public, the NHS, and the wider economy. Aimed to ease the burden on the NHS, the PAGB hopes that the suggest six key actions would help during the incoming winter illness season. According to PAGB, the NHS deals with approximately 25 million GP appointments and 5 million A&E visits each year for self-treatable conditions. By empowering individuals to manage their own health more effectively, the NHS could potentially save up to £1.7 billion annually. In her letter to Wes Streeting, Secretary of State for Health and Social Care, Michelle Riddalls, CEO of PAGB, urged the government to act promptly.

A new research - published in the BMJ (formerly the British Medical Journal) - says that according to an estimation, 2.51 lakh Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, after 6.11 lakh deaths due to heart disease and 5.85...

Dr Gokhale who is the founder secretary of the Heart Failure Society, India, has organised national meeting of the society on 19th & 20th April, 2014 at Hotel Manasarovar, Chiraan Fort Club, Begumpet, Hyderabad.

full body check-up package is essential because it helps us to identify the exact potential of the diseases at an early stage.

ITV on Tuesday (Aug 15) said it had agreed to invest in pain relief brand Flarin Holdings Ltd, making it the British broadcaster's first consumer healthcare investment. The company has agreed to subscribe for £2 million worth of shares in Flarin, with an option to subscribe for two more tranches of 1.5 million pounds each. In return, Flarin would get advertising space across ITV's channels and ITVX. ITV said its investment will "help Flarin build mass market brand awareness by bringing the brand to millions of consumers via ITV platforms. This will be a step change in the size of the campaign and the approach to scaling the Flarin brand to date." Director of ITV AdVentures, Sheena Amin, said: "It's fantastic to be announcing our latest Media for Equity investment into Flarin. With its innovative and patented lipid technology, Flarin offers many unique benefits to those suffering from joint and muscular pain compared to any other product on the market. Flarin is already one of the fastest growing analgesics in the market and I am confident that we will see the company grow to new heights following a brand building campaign across ITV."

2022 Surgery & Therapy Summit is organized by Surgery & Therapy Summit and will be held from Sep 09 - 12, 2022

PAFP Spring Family Medicine Essentials Summit is organized by the Pennsylvania Academy of Family Physicians and will be held from Apr 05 - 06, 2024 in Hershey. Upgrade your professional expertise by participating in the best-suited Family Medicine CME conferences and online courses and earning AMA PRA Category CME/CE credits.

Chiesi Farmaceutici, the international, research-focused biopharmaceuticals and healthcare group has acquired Amryt Pharma, a global biopharmaceutical company dedicated to developing novel treatments for rare diseases. More than 300 million people worldwide are affected by rare diseases, including those who are living with ultra-rare metabolic and dermatologic conditions who still have no approved treatment. The acquisition reinforces Chiesi's commitment to deliver innovative treatments to patients with highly unmet medical needs. As a benefit corporation and a B Corp, Chiesi strives to create a world where it is common to have a therapy for all diseases and acts as a force for good, for society and the planet. Chiesi's Head of Chiesi Global Rare diseases Giacomo Chiesi commented: "We are excited to add the Amryt family to our company in this acquisition that demonstrates our commitment to rare diseases and aligns with our growth strategy through partnerships beyond internal research and development." Chiesi's new CEO Giuseppe Accogli said: "By joining forces and expertise we will be able to grow our capabilities and further strengthen our position to provide a positive impact on patients living with rare diseases." With regard to the financing of the deal, cash consideration has been partially financed through a EUR 700m syndicated loan led by BNP Paribas and Crédit Agricole as Global Coordinators and ESG Structuring Banks, acting alongside BPER and Deutsche Bank as Mandated Lead Arrangers. Crédit Agricole is Loan Agent too. Lenders have been advised by Clifford Chance, while Baker and McKenzie has assisted Chiesi Farmaceutici.

In a remarkable turn of events, the NHS App has emerged as a financial saviour for the National Health Service, slashing costs by over £1 million in the last year alone. The revelation comes as a testament to the app's growing significance in streamlining patient communication and service delivery. Throughout the fiscal year 2023/24, a staggering 22.5 million messages traversed the NHS App, a feat previously reliant on traditional methods like text messages or letters. This monumental shift not only signifies a boon for efficiency but also heralds substantial savings, with each text message costing an average of 5p. Drastically reducing these expenses has amounted to a commendable £1.1 million in savings, marking a pivotal milestone in NHS expenditure management.

The Royal Pharmaceutical Society's (RPS) second roundtable on workforce wellbeing resulted in a series of collaborative actions to address pharmacy professionals' mental health and wellbeing challenges. The roundtable brought together key stakeholders from the pharmacy sector, including organisations like the General Pharmaceutical Council (GPhC), Community Pharmacy England (CPE), the National Pharmacy Association (NPA), and the profession's independent charity Pharmacist Support (PS). A report detailing the outcomes of the meeting was published on Friday, highlighting the key areas of discussion and the agreed-upon actions by the participants. During the roundtable, participants discussed the importance of understanding the workforce demographics, both nationally and locally, and using data to address wellbeing issues effectively. They also emphasised the need for using supportive standards set by the General Pharmaceutical Council (GPhC) and the Care Quality Commission (CQC) quality statement to support and empower pharmacists' wellbeing positively.